P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

March 2011

Features

A Comparison of Daily Average Consumption of Oxycodone Controlled Release (OxyContin CR) and Oxymorphone Extended Release (Opana ER) in Patients With Low Back Pain

In a retrospective study, patients needed one more oxycodone CR tablet per day compared with oxymorphone ER tablets to relieve pain. The authors suggest that switching patients from the highest oxycodone CR strength to the equivalent highest oxymorphone ER strength could generate significant savings in wholesale acquisition costs.
Todd Berner, MD; Heather Thomson, MBA, MS; Ann Hartry, PhD; R. Amy Puenpatom, PhD; Rami Ben-Joseph, PhD; and Sheryl L. Szeinbach, PhD, MS, BS Pharm

Opinion & Analysis

Doing More With Less?

Past and Present Challenges for the FDA

Over the years, the FDA has been given many new tasks without the resources to carry them out. The author opines that concentrating solely on regulating drugs and medical devices, simplifying funding procedures, and eliminating user fees could go a long way in strengthening the agency.
Jack McCain

Meeting Highlights

San Antonio Breast Cancer Symposium

Among the topics addressed were the contradictory effects of zoledronic acid (Zometa), a study on dual blockade of HER-2 with lapatinib (Tykerb) and trastuzumab (Herceptin), and a trial of combined everolimus (Afinitor) and tamoxifen (Nolvadex).
Walter Alexander

Meeting Highlights

American Society of Health-System Pharmacists

Stroke now accounts for one in 18 deaths in the U.S. Managing hypertensive crisis in acute ischemic stroke with thrombolytic agents while avoiding bleeding events, educating patients on signs and symptoms, and assessing patients’ neurological scores are some of the challenges inherent in delivering optimal care.
Edward H. Lee, PharmD

Pharmaceutical Approval Update

Topics include vilazodone (Viibryd) for major depressive disorder; spinosad topical suspension 0.9% (Natroba) in head lice infestation; and ioflupane iodine-123 injection (DaTscan), an imaging agent used for evaluating parkinsonian syndromes.
Marvin M. Goldenberg, PhD, RPh, MS

Departments

Editorial

The Patient Safety Act

Dr. Nash discusses the implications of the Patient Safety Act for P&T committee members.
David B. Nash, MD, MBA

Medication Errors

Reducing the Potential for Mistakes With Investigational Drugs

Decreasing the potential for mistakes with investigational drugs
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Medicare to Roll Out Value-Based Purchasing Scorecards in July

Hospital Payments Will Depend on Performance in Fiscal Year 2013

Medicare will soon announce rules of the road for value-based purchasing payments.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Drug Forecast

Telavancin (Vibativ), a New Option for the Treatment of Gram-Positive Infections

Telavancin (Vibativ) for the treatment of gram-positive infections
Polina Plotkin, PharmD; Khusbu Patel, PharmD; Amy Uminski, PharmD; and Nino Marzella, BS, MS, PharmD